Cartesian Growth Corporation II
Get $10 bonus on your first $100 deposit for RENEF
Get $10 bonus on your first $100 deposit for RENEF
Cartesian Growth Corporation II (RENEF) Stock Competitors & Peer Comparison
See (RENEF) competitors and their performances in Stock Market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RENEF | $12.71 | +0.00% | 165.2M | -74.76 | -$0.17 | N/A |
| QMIS | $0.25 | +0.00% | 30.5B | N/A | N/A | N/A |
| GSHN | $22.70 | +2.71% | 9.3B | -2270.00 | -$0.01 | N/A |
| KATX | $1.05 | +0.00% | 1.9B | N/A | N/A | N/A |
| CCYC | $11.25 | +0.00% | 1.7B | N/A | N/A | N/A |
| WPCBF | $0.00 | +100.00% | 700.3M | N/A | N/A | N/A |
| NOTR | $13.00 | +0.00% | 570.9M | -433.33 | -$0.03 | N/A |
| WCHS | $5.01 | +0.00% | 531.9M | N/A | N/A | N/A |
| FZRO | $2.00 | N/A | 346.2M | -0.00 | -$4,243,300.50 | N/A |
| RGLG | $1.13 | +11.88% | 342.8M | -0.11 | -$10.00 | N/A |
Stock Comparison
RENEF vs QMIS Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, QMIS has a market cap of 30.5B. Regarding current trading prices, RENEF is priced at $12.71, while QMIS trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas QMIS's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to QMIS's ROE of N/A. Regarding short-term risk, RENEF is more volatile compared to QMIS. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check QMIS's competition here
RENEF vs GSHN Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GSHN has a market cap of 9.3B. Regarding current trading prices, RENEF is priced at $12.71, while GSHN trades at $22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GSHN's P/E ratio is -2270.00. In terms of profitability, RENEF's ROE is +0.84%, compared to GSHN's ROE of +0.07%. Regarding short-term risk, RENEF is more volatile compared to GSHN. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check GSHN's competition here
RENEF vs KATX Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, KATX has a market cap of 1.9B. Regarding current trading prices, RENEF is priced at $12.71, while KATX trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas KATX's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to KATX's ROE of +2.21%. Regarding short-term risk, RENEF is less volatile compared to KATX. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check KATX's competition here
RENEF vs CCYC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CCYC has a market cap of 1.7B. Regarding current trading prices, RENEF is priced at $12.71, while CCYC trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CCYC's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to CCYC's ROE of +1.16%. Regarding short-term risk, RENEF is more volatile compared to CCYC. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CCYC's competition here
RENEF vs WPCBF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WPCBF has a market cap of 700.3M. Regarding current trading prices, RENEF is priced at $12.71, while WPCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WPCBF's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to WPCBF's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to WPCBF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check WPCBF's competition here
RENEF vs NOTR Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NOTR has a market cap of 570.9M. Regarding current trading prices, RENEF is priced at $12.71, while NOTR trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NOTR's P/E ratio is -433.33. In terms of profitability, RENEF's ROE is +0.84%, compared to NOTR's ROE of +0.42%. Regarding short-term risk, RENEF is less volatile compared to NOTR. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check NOTR's competition here
RENEF vs WCHS Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WCHS has a market cap of 531.9M. Regarding current trading prices, RENEF is priced at $12.71, while WCHS trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WCHS's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to WCHS's ROE of +1.70%. Regarding short-term risk, RENEF is less volatile compared to WCHS. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check WCHS's competition here
RENEF vs FZRO Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, FZRO has a market cap of 346.2M. Regarding current trading prices, RENEF is priced at $12.71, while FZRO trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas FZRO's P/E ratio is -0.00. In terms of profitability, RENEF's ROE is +0.84%, compared to FZRO's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to FZRO. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check FZRO's competition here
RENEF vs RGLG Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, RGLG has a market cap of 342.8M. Regarding current trading prices, RENEF is priced at $12.71, while RGLG trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas RGLG's P/E ratio is -0.11. In terms of profitability, RENEF's ROE is +0.84%, compared to RGLG's ROE of -1.03%. Regarding short-term risk, RENEF is less volatile compared to RGLG. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check RGLG's competition here
RENEF vs CINV Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CINV has a market cap of 338.6M. Regarding current trading prices, RENEF is priced at $12.71, while CINV trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CINV's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to CINV's ROE of +0.59%. Regarding short-term risk, RENEF is more volatile compared to CINV. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CINV's competition here
RENEF vs DVTC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, DVTC has a market cap of 272.5M. Regarding current trading prices, RENEF is priced at $12.71, while DVTC trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas DVTC's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to DVTC's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to DVTC. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check DVTC's competition here
RENEF vs AMRR Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AMRR has a market cap of 250.6M. Regarding current trading prices, RENEF is priced at $12.71, while AMRR trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AMRR's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to AMRR's ROE of +0.70%. Regarding short-term risk, RENEF is more volatile compared to AMRR. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check AMRR's competition here
RENEF vs KAST Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, KAST has a market cap of 164.6M. Regarding current trading prices, RENEF is priced at $12.71, while KAST trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas KAST's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to KAST's ROE of -0.25%. Regarding short-term risk, RENEF is less volatile compared to KAST. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check KAST's competition here
RENEF vs TGLO Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, TGLO has a market cap of 154.5M. Regarding current trading prices, RENEF is priced at $12.71, while TGLO trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas TGLO's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to TGLO's ROE of +0.29%. Regarding short-term risk, RENEF is less volatile compared to TGLO. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check TGLO's competition here
RENEF vs GWIN Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GWIN has a market cap of 149.6M. Regarding current trading prices, RENEF is priced at $12.71, while GWIN trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GWIN's P/E ratio is -0.93. In terms of profitability, RENEF's ROE is +0.84%, compared to GWIN's ROE of +0.00%. Regarding short-term risk, RENEF is less volatile compared to GWIN. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check GWIN's competition here
RENEF vs SCGX Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, SCGX has a market cap of 140.7M. Regarding current trading prices, RENEF is priced at $12.71, while SCGX trades at $7.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas SCGX's P/E ratio is -0.01. In terms of profitability, RENEF's ROE is +0.84%, compared to SCGX's ROE of -0.26%. Regarding short-term risk, RENEF is more volatile compared to SCGX. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check SCGX's competition here
RENEF vs AGGI Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AGGI has a market cap of 120.8M. Regarding current trading prices, RENEF is priced at $12.71, while AGGI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AGGI's P/E ratio is 2.99. In terms of profitability, RENEF's ROE is +0.84%, compared to AGGI's ROE of +0.98%. Regarding short-term risk, RENEF is less volatile compared to AGGI. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check AGGI's competition here
RENEF vs GARLF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GARLF has a market cap of 119.9M. Regarding current trading prices, RENEF is priced at $12.71, while GARLF trades at $3.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GARLF's P/E ratio is -11.22. In terms of profitability, RENEF's ROE is +0.84%, compared to GARLF's ROE of -0.59%. Regarding short-term risk, RENEF is less volatile compared to GARLF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check GARLF's competition here
RENEF vs CNXX Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CNXX has a market cap of 118.3M. Regarding current trading prices, RENEF is priced at $12.71, while CNXX trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CNXX's P/E ratio is 52.08. In terms of profitability, RENEF's ROE is +0.84%, compared to CNXX's ROE of +8.72%. Regarding short-term risk, RENEF is more volatile compared to CNXX. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CNXX's competition here
RENEF vs TRFE Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, TRFE has a market cap of 101M. Regarding current trading prices, RENEF is priced at $12.71, while TRFE trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas TRFE's P/E ratio is -1.92. In terms of profitability, RENEF's ROE is +0.84%, compared to TRFE's ROE of -0.27%. Regarding short-term risk, RENEF is more volatile compared to TRFE. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check TRFE's competition here
RENEF vs NMTT Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NMTT has a market cap of 90.6M. Regarding current trading prices, RENEF is priced at $12.71, while NMTT trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NMTT's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to NMTT's ROE of N/A. Regarding short-term risk, RENEF is more volatile compared to NMTT. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check NMTT's competition here
RENEF vs ISRLF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ISRLF has a market cap of 90.2M. Regarding current trading prices, RENEF is priced at $12.71, while ISRLF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ISRLF's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to ISRLF's ROE of +0.20%. Regarding short-term risk, RENEF is less volatile compared to ISRLF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ISRLF's competition here
RENEF vs RMGCF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, RMGCF has a market cap of 89.2M. Regarding current trading prices, RENEF is priced at $12.71, while RMGCF trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas RMGCF's P/E ratio is -14.41. In terms of profitability, RENEF's ROE is +0.84%, compared to RMGCF's ROE of +0.03%. Regarding short-term risk, RENEF is less volatile compared to RMGCF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check RMGCF's competition here
RENEF vs IXAQF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, IXAQF has a market cap of 88.8M. Regarding current trading prices, RENEF is priced at $12.71, while IXAQF trades at $12.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas IXAQF's P/E ratio is -86.14. In terms of profitability, RENEF's ROE is +0.84%, compared to IXAQF's ROE of +0.08%. Regarding short-term risk, RENEF is less volatile compared to IXAQF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check IXAQF's competition here
RENEF vs XTPT Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, XTPT has a market cap of 87.7M. Regarding current trading prices, RENEF is priced at $12.71, while XTPT trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas XTPT's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to XTPT's ROE of -8.42%. Regarding short-term risk, RENEF is less volatile compared to XTPT. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check XTPT's competition here
RENEF vs WAYS Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WAYS has a market cap of 86.5M. Regarding current trading prices, RENEF is priced at $12.71, while WAYS trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WAYS's P/E ratio is -49.72. In terms of profitability, RENEF's ROE is +0.84%, compared to WAYS's ROE of -0.14%. Regarding short-term risk, RENEF is more volatile compared to WAYS. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check WAYS's competition here
RENEF vs USCTF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, USCTF has a market cap of 85.9M. Regarding current trading prices, RENEF is priced at $12.71, while USCTF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas USCTF's P/E ratio is -19.00. In terms of profitability, RENEF's ROE is +0.84%, compared to USCTF's ROE of +0.94%. Regarding short-term risk, RENEF is more volatile compared to USCTF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check USCTF's competition here
RENEF vs ATAQF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ATAQF has a market cap of 82.4M. Regarding current trading prices, RENEF is priced at $12.71, while ATAQF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ATAQF's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to ATAQF's ROE of +0.07%. Regarding short-term risk, RENEF is less volatile compared to ATAQF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ATAQF's competition here
RENEF vs WWHC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WWHC has a market cap of 80.2M. Regarding current trading prices, RENEF is priced at $12.71, while WWHC trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WWHC's P/E ratio is -2.11. In terms of profitability, RENEF's ROE is +0.84%, compared to WWHC's ROE of +1.06%. Regarding short-term risk, RENEF is more volatile compared to WWHC. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check WWHC's competition here
RENEF vs IVCAF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, IVCAF has a market cap of 77.9M. Regarding current trading prices, RENEF is priced at $12.71, while IVCAF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas IVCAF's P/E ratio is -600.00. In terms of profitability, RENEF's ROE is +0.84%, compared to IVCAF's ROE of -0.01%. Regarding short-term risk, RENEF is more volatile compared to IVCAF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check IVCAF's competition here
RENEF vs CHAAW Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CHAAW has a market cap of 77.6M. Regarding current trading prices, RENEF is priced at $12.71, while CHAAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CHAAW's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to CHAAW's ROE of -0.04%. Regarding short-term risk, RENEF is more volatile compared to CHAAW. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CHAAW's competition here
RENEF vs CREEF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CREEF has a market cap of 75M. Regarding current trading prices, RENEF is priced at $12.71, while CREEF trades at $10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CREEF's P/E ratio is 36.47. In terms of profitability, RENEF's ROE is +0.84%, compared to CREEF's ROE of +0.16%. Regarding short-term risk, RENEF is more volatile compared to CREEF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CREEF's competition here
RENEF vs CMCAF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CMCAF has a market cap of 67.9M. Regarding current trading prices, RENEF is priced at $12.71, while CMCAF trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CMCAF's P/E ratio is 60.00. In terms of profitability, RENEF's ROE is +0.84%, compared to CMCAF's ROE of +5.07%. Regarding short-term risk, RENEF is more volatile compared to CMCAF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CMCAF's competition here
RENEF vs ASCBF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ASCBF has a market cap of 62.9M. Regarding current trading prices, RENEF is priced at $12.71, while ASCBF trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ASCBF's P/E ratio is 24.47. In terms of profitability, RENEF's ROE is +0.84%, compared to ASCBF's ROE of +0.03%. Regarding short-term risk, RENEF is less volatile compared to ASCBF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ASCBF's competition here
RENEF vs IDIG Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, IDIG has a market cap of 62.3M. Regarding current trading prices, RENEF is priced at $12.71, while IDIG trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas IDIG's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to IDIG's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to IDIG. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check IDIG's competition here
RENEF vs HAIAF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, HAIAF has a market cap of 60.2M. Regarding current trading prices, RENEF is priced at $12.71, while HAIAF trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas HAIAF's P/E ratio is -217.20. In terms of profitability, RENEF's ROE is +0.84%, compared to HAIAF's ROE of -0.16%. Regarding short-term risk, RENEF is more volatile compared to HAIAF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check HAIAF's competition here
RENEF vs PTCP Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, PTCP has a market cap of 56.7M. Regarding current trading prices, RENEF is priced at $12.71, while PTCP trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas PTCP's P/E ratio is -27.78. In terms of profitability, RENEF's ROE is +0.84%, compared to PTCP's ROE of N/A. Regarding short-term risk, RENEF is more volatile compared to PTCP. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check PTCP's competition here
RENEF vs ATMS Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ATMS has a market cap of 55.8M. Regarding current trading prices, RENEF is priced at $12.71, while ATMS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ATMS's P/E ratio is -8.30. In terms of profitability, RENEF's ROE is +0.84%, compared to ATMS's ROE of +1.78%. Regarding short-term risk, RENEF is more volatile compared to ATMS. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check ATMS's competition here
RENEF vs GGAAF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GGAAF has a market cap of 50.7M. Regarding current trading prices, RENEF is priced at $12.71, while GGAAF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GGAAF's P/E ratio is -133.33. In terms of profitability, RENEF's ROE is +0.84%, compared to GGAAF's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to GGAAF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check GGAAF's competition here
RENEF vs JMTM Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, JMTM has a market cap of 48M. Regarding current trading prices, RENEF is priced at $12.71, while JMTM trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas JMTM's P/E ratio is -10.00. In terms of profitability, RENEF's ROE is +0.84%, compared to JMTM's ROE of +3.01%. Regarding short-term risk, RENEF is less volatile compared to JMTM. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check JMTM's competition here
RENEF vs KWAC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, KWAC has a market cap of 46.2M. Regarding current trading prices, RENEF is priced at $12.71, while KWAC trades at $13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas KWAC's P/E ratio is -23.75. In terms of profitability, RENEF's ROE is +0.84%, compared to KWAC's ROE of +0.03%. Regarding short-term risk, RENEF is more volatile compared to KWAC. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check KWAC's competition here
RENEF vs KWACW Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, KWACW has a market cap of 46.2M. Regarding current trading prices, RENEF is priced at $12.71, while KWACW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas KWACW's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to KWACW's ROE of +0.03%. Regarding short-term risk, RENEF is more volatile compared to KWACW. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check KWACW's competition here
RENEF vs AASP Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AASP has a market cap of 45.7M. Regarding current trading prices, RENEF is priced at $12.71, while AASP trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AASP's P/E ratio is -4.85. In terms of profitability, RENEF's ROE is +0.84%, compared to AASP's ROE of -6.40%. Regarding short-term risk, RENEF is more volatile compared to AASP. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check AASP's competition here
RENEF vs FSTJ Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, FSTJ has a market cap of 43.5M. Regarding current trading prices, RENEF is priced at $12.71, while FSTJ trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas FSTJ's P/E ratio is -49.50. In terms of profitability, RENEF's ROE is +0.84%, compared to FSTJ's ROE of +0.24%. Regarding short-term risk, RENEF is more volatile compared to FSTJ. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check FSTJ's competition here
RENEF vs TETEF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, TETEF has a market cap of 41.3M. Regarding current trading prices, RENEF is priced at $12.71, while TETEF trades at $12.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas TETEF's P/E ratio is 402.67. In terms of profitability, RENEF's ROE is +0.84%, compared to TETEF's ROE of +0.11%. Regarding short-term risk, RENEF is less volatile compared to TETEF. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check TETEF's competition here
RENEF vs MSSAF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, MSSAF has a market cap of 40.8M. Regarding current trading prices, RENEF is priced at $12.71, while MSSAF trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas MSSAF's P/E ratio is -6.10. In terms of profitability, RENEF's ROE is +0.84%, compared to MSSAF's ROE of +0.09%. Regarding short-term risk, RENEF is more volatile compared to MSSAF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check MSSAF's competition here
RENEF vs AOAO Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AOAO has a market cap of 39M. Regarding current trading prices, RENEF is priced at $12.71, while AOAO trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AOAO's P/E ratio is -3.64. In terms of profitability, RENEF's ROE is +0.84%, compared to AOAO's ROE of +9.96%. Regarding short-term risk, RENEF is less volatile compared to AOAO. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check AOAO's competition here
RENEF vs ACBD Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ACBD has a market cap of 33.8M. Regarding current trading prices, RENEF is priced at $12.71, while ACBD trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ACBD's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to ACBD's ROE of +1.16%. Regarding short-term risk, RENEF is more volatile compared to ACBD. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check ACBD's competition here
RENEF vs MDWK Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, MDWK has a market cap of 33M. Regarding current trading prices, RENEF is priced at $12.71, while MDWK trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas MDWK's P/E ratio is -7.00. In terms of profitability, RENEF's ROE is +0.84%, compared to MDWK's ROE of -2.80%. Regarding short-term risk, RENEF is less volatile compared to MDWK. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check MDWK's competition here
RENEF vs ATMH Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ATMH has a market cap of 32M. Regarding current trading prices, RENEF is priced at $12.71, while ATMH trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ATMH's P/E ratio is -5.90. In terms of profitability, RENEF's ROE is +0.84%, compared to ATMH's ROE of -0.20%. Regarding short-term risk, RENEF is more volatile compared to ATMH. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check ATMH's competition here
RENEF vs AVNI Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AVNI has a market cap of 31.6M. Regarding current trading prices, RENEF is priced at $12.71, while AVNI trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AVNI's P/E ratio is -24.86. In terms of profitability, RENEF's ROE is +0.84%, compared to AVNI's ROE of +1.17%. Regarding short-term risk, RENEF is more volatile compared to AVNI. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check AVNI's competition here
RENEF vs CLRCF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CLRCF has a market cap of 30.7M. Regarding current trading prices, RENEF is priced at $12.71, while CLRCF trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CLRCF's P/E ratio is -93.08. In terms of profitability, RENEF's ROE is +0.84%, compared to CLRCF's ROE of +0.09%. Regarding short-term risk, RENEF is more volatile compared to CLRCF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CLRCF's competition here
RENEF vs AZRH Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AZRH has a market cap of 29.3M. Regarding current trading prices, RENEF is priced at $12.71, while AZRH trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AZRH's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to AZRH's ROE of -0.11%. Regarding short-term risk, RENEF is less volatile compared to AZRH. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check AZRH's competition here
RENEF vs AWCA Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, AWCA has a market cap of 29M. Regarding current trading prices, RENEF is priced at $12.71, while AWCA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas AWCA's P/E ratio is -7.10. In terms of profitability, RENEF's ROE is +0.84%, compared to AWCA's ROE of -0.41%. Regarding short-term risk, RENEF is more volatile compared to AWCA. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check AWCA's competition here
RENEF vs WBQNL Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WBQNL has a market cap of 28.7M. Regarding current trading prices, RENEF is priced at $12.71, while WBQNL trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WBQNL's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to WBQNL's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to WBQNL. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check WBQNL's competition here
RENEF vs RAFX Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, RAFX has a market cap of 27.3M. Regarding current trading prices, RENEF is priced at $12.71, while RAFX trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas RAFX's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to RAFX's ROE of -0.06%. Regarding short-term risk, RENEF is less volatile compared to RAFX. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check RAFX's competition here
RENEF vs ADCV Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ADCV has a market cap of 26.7M. Regarding current trading prices, RENEF is priced at $12.71, while ADCV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ADCV's P/E ratio is -0.64. In terms of profitability, RENEF's ROE is +0.84%, compared to ADCV's ROE of N/A. Regarding short-term risk, RENEF is more volatile compared to ADCV. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check ADCV's competition here
RENEF vs PSCO Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, PSCO has a market cap of 26.4M. Regarding current trading prices, RENEF is priced at $12.71, while PSCO trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas PSCO's P/E ratio is -0.40. In terms of profitability, RENEF's ROE is +0.84%, compared to PSCO's ROE of +0.00%. Regarding short-term risk, RENEF is less volatile compared to PSCO. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check PSCO's competition here
RENEF vs NPFC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NPFC has a market cap of 23.9M. Regarding current trading prices, RENEF is priced at $12.71, while NPFC trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NPFC's P/E ratio is -17.86. In terms of profitability, RENEF's ROE is +0.84%, compared to NPFC's ROE of +1.75%. Regarding short-term risk, RENEF is more volatile compared to NPFC. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check NPFC's competition here
RENEF vs ITRX Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ITRX has a market cap of 23.8M. Regarding current trading prices, RENEF is priced at $12.71, while ITRX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ITRX's P/E ratio is -7.69. In terms of profitability, RENEF's ROE is +0.84%, compared to ITRX's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to ITRX. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ITRX's competition here
RENEF vs CBBB Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CBBB has a market cap of 22.1M. Regarding current trading prices, RENEF is priced at $12.71, while CBBB trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CBBB's P/E ratio is -0.87. In terms of profitability, RENEF's ROE is +0.84%, compared to CBBB's ROE of +0.00%. Regarding short-term risk, RENEF is less volatile compared to CBBB. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check CBBB's competition here
RENEF vs GIPL Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GIPL has a market cap of 20.6M. Regarding current trading prices, RENEF is priced at $12.71, while GIPL trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GIPL's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to GIPL's ROE of -3.74%. Regarding short-term risk, RENEF is less volatile compared to GIPL. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check GIPL's competition here
RENEF vs ADIA Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ADIA has a market cap of 18.9M. Regarding current trading prices, RENEF is priced at $12.71, while ADIA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ADIA's P/E ratio is -0.50. In terms of profitability, RENEF's ROE is +0.84%, compared to ADIA's ROE of +3.07%. Regarding short-term risk, RENEF is more volatile compared to ADIA. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check ADIA's competition here
RENEF vs LRGR Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, LRGR has a market cap of 17.3M. Regarding current trading prices, RENEF is priced at $12.71, while LRGR trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas LRGR's P/E ratio is -0.02. In terms of profitability, RENEF's ROE is +0.84%, compared to LRGR's ROE of +0.15%. Regarding short-term risk, RENEF is less volatile compared to LRGR. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check LRGR's competition here
RENEF vs PCMC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, PCMC has a market cap of 15.8M. Regarding current trading prices, RENEF is priced at $12.71, while PCMC trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas PCMC's P/E ratio is -2.30. In terms of profitability, RENEF's ROE is +0.84%, compared to PCMC's ROE of +0.22%. Regarding short-term risk, RENEF is less volatile compared to PCMC. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check PCMC's competition here
RENEF vs GTVI Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GTVI has a market cap of 15.3M. Regarding current trading prices, RENEF is priced at $12.71, while GTVI trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GTVI's P/E ratio is -3.65. In terms of profitability, RENEF's ROE is +0.84%, compared to GTVI's ROE of +0.78%. Regarding short-term risk, RENEF is more volatile compared to GTVI. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check GTVI's competition here
RENEF vs WRPT Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WRPT has a market cap of 14.7M. Regarding current trading prices, RENEF is priced at $12.71, while WRPT trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WRPT's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to WRPT's ROE of -0.15%. Regarding short-term risk, RENEF is more volatile compared to WRPT. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check WRPT's competition here
RENEF vs BTOW Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, BTOW has a market cap of 14.2M. Regarding current trading prices, RENEF is priced at $12.71, while BTOW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas BTOW's P/E ratio is -0.10. In terms of profitability, RENEF's ROE is +0.84%, compared to BTOW's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to BTOW. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check BTOW's competition here
RENEF vs SIPN Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, SIPN has a market cap of 14.2M. Regarding current trading prices, RENEF is priced at $12.71, while SIPN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas SIPN's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to SIPN's ROE of +0.01%. Regarding short-term risk, RENEF is more volatile compared to SIPN. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check SIPN's competition here
RENEF vs ECGR Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ECGR has a market cap of 13.4M. Regarding current trading prices, RENEF is priced at $12.71, while ECGR trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ECGR's P/E ratio is -20.00. In terms of profitability, RENEF's ROE is +0.84%, compared to ECGR's ROE of -1.14%. Regarding short-term risk, RENEF is less volatile compared to ECGR. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ECGR's competition here
RENEF vs USBL Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, USBL has a market cap of 13.1M. Regarding current trading prices, RENEF is priced at $12.71, while USBL trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas USBL's P/E ratio is -0.81. In terms of profitability, RENEF's ROE is +0.84%, compared to USBL's ROE of +0.12%. Regarding short-term risk, RENEF is less volatile compared to USBL. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check USBL's competition here
RENEF vs STLY Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, STLY has a market cap of 12.1M. Regarding current trading prices, RENEF is priced at $12.71, while STLY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas STLY's P/E ratio is 11.28. In terms of profitability, RENEF's ROE is +0.84%, compared to STLY's ROE of +0.04%. Regarding short-term risk, RENEF is more volatile compared to STLY. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check STLY's competition here
RENEF vs CAHO Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CAHO has a market cap of 11.9M. Regarding current trading prices, RENEF is priced at $12.71, while CAHO trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CAHO's P/E ratio is -32.00. In terms of profitability, RENEF's ROE is +0.84%, compared to CAHO's ROE of +0.40%. Regarding short-term risk, RENEF is more volatile compared to CAHO. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CAHO's competition here
RENEF vs CMCUF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CMCUF has a market cap of 11.8M. Regarding current trading prices, RENEF is priced at $12.71, while CMCUF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CMCUF's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to CMCUF's ROE of +5.07%. Regarding short-term risk, RENEF is more volatile compared to CMCUF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CMCUF's competition here
RENEF vs XCPT Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, XCPT has a market cap of 11.4M. Regarding current trading prices, RENEF is priced at $12.71, while XCPT trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas XCPT's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to XCPT's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to XCPT. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check XCPT's competition here
RENEF vs WNFT Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, WNFT has a market cap of 10.1M. Regarding current trading prices, RENEF is priced at $12.71, while WNFT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas WNFT's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to WNFT's ROE of +0.00%. Regarding short-term risk, RENEF is less volatile compared to WNFT. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check WNFT's competition here
RENEF vs EDGM Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, EDGM has a market cap of 10M. Regarding current trading prices, RENEF is priced at $12.71, while EDGM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas EDGM's P/E ratio is -0.21. In terms of profitability, RENEF's ROE is +0.84%, compared to EDGM's ROE of +2.36%. Regarding short-term risk, RENEF is less volatile compared to EDGM. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check EDGM's competition here
RENEF vs ELLH Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ELLH has a market cap of 10M. Regarding current trading prices, RENEF is priced at $12.71, while ELLH trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ELLH's P/E ratio is -4.14. In terms of profitability, RENEF's ROE is +0.84%, compared to ELLH's ROE of -0.40%. Regarding short-term risk, RENEF is less volatile compared to ELLH. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ELLH's competition here
RENEF vs BOREF Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, BOREF has a market cap of 9.9M. Regarding current trading prices, RENEF is priced at $12.71, while BOREF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas BOREF's P/E ratio is -22.22. In terms of profitability, RENEF's ROE is +0.84%, compared to BOREF's ROE of +0.06%. Regarding short-term risk, RENEF is more volatile compared to BOREF. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check BOREF's competition here
RENEF vs TCRI Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, TCRI has a market cap of 8.8M. Regarding current trading prices, RENEF is priced at $12.71, while TCRI trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas TCRI's P/E ratio is -13.50. In terms of profitability, RENEF's ROE is +0.84%, compared to TCRI's ROE of +0.19%. Regarding short-term risk, RENEF is less volatile compared to TCRI. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check TCRI's competition here
RENEF vs LWLW Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, LWLW has a market cap of 8.1M. Regarding current trading prices, RENEF is priced at $12.71, while LWLW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas LWLW's P/E ratio is -10.00. In terms of profitability, RENEF's ROE is +0.84%, compared to LWLW's ROE of -19.61%. Regarding short-term risk, RENEF is more volatile compared to LWLW. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check LWLW's competition here
RENEF vs NIMU Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NIMU has a market cap of 7.7M. Regarding current trading prices, RENEF is priced at $12.71, while NIMU trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NIMU's P/E ratio is -0.28. In terms of profitability, RENEF's ROE is +0.84%, compared to NIMU's ROE of +0.20%. Regarding short-term risk, RENEF is less volatile compared to NIMU. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check NIMU's competition here
RENEF vs EVTK Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, EVTK has a market cap of 7.5M. Regarding current trading prices, RENEF is priced at $12.71, while EVTK trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas EVTK's P/E ratio is -180.00. In terms of profitability, RENEF's ROE is +0.84%, compared to EVTK's ROE of +0.61%. Regarding short-term risk, RENEF is less volatile compared to EVTK. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check EVTK's competition here
RENEF vs ADHI Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ADHI has a market cap of 7.4M. Regarding current trading prices, RENEF is priced at $12.71, while ADHI trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ADHI's P/E ratio is -0.04. In terms of profitability, RENEF's ROE is +0.84%, compared to ADHI's ROE of -0.72%. Regarding short-term risk, RENEF is less volatile compared to ADHI. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ADHI's competition here
RENEF vs NGRC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NGRC has a market cap of 6.9M. Regarding current trading prices, RENEF is priced at $12.71, while NGRC trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NGRC's P/E ratio is -2.25. In terms of profitability, RENEF's ROE is +0.84%, compared to NGRC's ROE of +0.05%. Regarding short-term risk, RENEF is less volatile compared to NGRC. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check NGRC's competition here
RENEF vs SDAD Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, SDAD has a market cap of 6.4M. Regarding current trading prices, RENEF is priced at $12.71, while SDAD trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas SDAD's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to SDAD's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to SDAD. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check SDAD's competition here
RENEF vs NXMH Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NXMH has a market cap of 6.1M. Regarding current trading prices, RENEF is priced at $12.71, while NXMH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NXMH's P/E ratio is -1.40. In terms of profitability, RENEF's ROE is +0.84%, compared to NXMH's ROE of +0.30%. Regarding short-term risk, RENEF is less volatile compared to NXMH. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check NXMH's competition here
RENEF vs LNMG Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, LNMG has a market cap of 6.1M. Regarding current trading prices, RENEF is priced at $12.71, while LNMG trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas LNMG's P/E ratio is 1.20. In terms of profitability, RENEF's ROE is +0.84%, compared to LNMG's ROE of +0.02%. Regarding short-term risk, RENEF is less volatile compared to LNMG. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check LNMG's competition here
RENEF vs ARVY Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ARVY has a market cap of 6M. Regarding current trading prices, RENEF is priced at $12.71, while ARVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ARVY's P/E ratio is -0.40. In terms of profitability, RENEF's ROE is +0.84%, compared to ARVY's ROE of +0.11%. Regarding short-term risk, RENEF is less volatile compared to ARVY. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ARVY's competition here
RENEF vs NRCD Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, NRCD has a market cap of 5.2M. Regarding current trading prices, RENEF is priced at $12.71, while NRCD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas NRCD's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to NRCD's ROE of N/A. Regarding short-term risk, RENEF is more volatile compared to NRCD. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check NRCD's competition here
RENEF vs HGYN Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, HGYN has a market cap of 5.2M. Regarding current trading prices, RENEF is priced at $12.71, while HGYN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas HGYN's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to HGYN's ROE of -0.28%. Regarding short-term risk, RENEF is less volatile compared to HGYN. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check HGYN's competition here
RENEF vs BBLC Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, BBLC has a market cap of 5.1M. Regarding current trading prices, RENEF is priced at $12.71, while BBLC trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas BBLC's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to BBLC's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to BBLC. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check BBLC's competition here
RENEF vs ASNB Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, ASNB has a market cap of 4.8M. Regarding current trading prices, RENEF is priced at $12.71, while ASNB trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas ASNB's P/E ratio is -0.60. In terms of profitability, RENEF's ROE is +0.84%, compared to ASNB's ROE of -0.07%. Regarding short-term risk, RENEF is less volatile compared to ASNB. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check ASNB's competition here
RENEF vs MTRI Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, MTRI has a market cap of 4.6M. Regarding current trading prices, RENEF is priced at $12.71, while MTRI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas MTRI's P/E ratio is 12.50. In terms of profitability, RENEF's ROE is +0.84%, compared to MTRI's ROE of N/A. Regarding short-term risk, RENEF is less volatile compared to MTRI. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check MTRI's competition here
RENEF vs PLPL Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, PLPL has a market cap of 4.5M. Regarding current trading prices, RENEF is priced at $12.71, while PLPL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas PLPL's P/E ratio is -0.01. In terms of profitability, RENEF's ROE is +0.84%, compared to PLPL's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to PLPL. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check PLPL's competition here
RENEF vs GPLL Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, GPLL has a market cap of 4.2M. Regarding current trading prices, RENEF is priced at $12.71, while GPLL trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas GPLL's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to GPLL's ROE of +0.00%. Regarding short-term risk, RENEF is more volatile compared to GPLL. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check GPLL's competition here
RENEF vs CDBT Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CDBT has a market cap of 4.1M. Regarding current trading prices, RENEF is priced at $12.71, while CDBT trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CDBT's P/E ratio is -5.00. In terms of profitability, RENEF's ROE is +0.84%, compared to CDBT's ROE of +1.55%. Regarding short-term risk, RENEF is less volatile compared to CDBT. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check CDBT's competition here
RENEF vs SMEV Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, SMEV has a market cap of 3.9M. Regarding current trading prices, RENEF is priced at $12.71, while SMEV trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas SMEV's P/E ratio is N/A. In terms of profitability, RENEF's ROE is +0.84%, compared to SMEV's ROE of +0.19%. Regarding short-term risk, RENEF is less volatile compared to SMEV. This indicates potentially lower risk in terms of short-term price fluctuations for RENEF.Check SMEV's competition here
RENEF vs CHYL Comparison April 2026
RENEF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENEF stands at 165.2M. In comparison, CHYL has a market cap of 3.9M. Regarding current trading prices, RENEF is priced at $12.71, while CHYL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENEF currently has a P/E ratio of -74.76, whereas CHYL's P/E ratio is 6.53. In terms of profitability, RENEF's ROE is +0.84%, compared to CHYL's ROE of +0.23%. Regarding short-term risk, RENEF is more volatile compared to CHYL. This indicates potentially higher risk in terms of short-term price fluctuations for RENEF.Check CHYL's competition here